Influx Healthtech Limited — Quarterly Results & Earnings

₹202.00

-4.92%

Profit Growth YoY78.11%Latest quarter

Sales Growth YoY38.91%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+78.11%

🔥 Exceptional growth

YoY Sales Growth+38.91%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

N/A

ROE

45.38%

ROCE

60.16%

💡

Growth Analysis

Influx Healthtech Limited reported YoY profit growth of 78.11% and revenue growth of 38.91% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Influx Healthtech Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.